VR-496

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameVR-496

Drug Alias Nameheparin (inhaled, cystic fibrosis/COPD/asthma, PowderHale), VecturaInhaled heparinHeparin inhalationHeparin inhalation - Vectura

ClassificationSmall molecules > Carbohydrate

Mechanisms of ActionCell adhesion molecules inhibitorsInflammation mediators inhibitorsHeparanase inhibitors

TargetsCell adhesion moleculesHeparanase

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVectura Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVectura Ltd

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaCystic Fibrosis

ATC CodeN/A